Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.

Chlenski A, Guerrero LJ, Peddinti R, Spitz JA, Leonhardt PT, Yang Q, Tian Y, Salwen HR, Cohn SL.

Mol Cancer. 2010 Jun 4;9:138. doi: 10.1186/1476-4598-9-138.

PMID:
20525313
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

Pastorino F, Di Paolo D, Loi M, Becherini P, Caffa I, Zorzoli A, Marimpietri D, Carosio R, Perri P, Montaldo PG, Brignole C, Pagnan G, Ribatti D, Allen TM, Ponzoni M.

Curr Drug Targets. 2009 Oct;10(10):1021-7. Review.

PMID:
19663770
[PubMed - indexed for MEDLINE]
3.

Angiogenesis in neuroblastoma.

Ribatti D, Marimpietri D, Pastorino F, Brignole C, Nico B, Vacca A, Ponzoni M.

Ann N Y Acad Sci. 2004 Dec;1028:133-42. Review.

PMID:
15650239
[PubMed - indexed for MEDLINE]
4.

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.

Kerbel RS, Viloria-Petit A, Klement G, Rak J.

Eur J Cancer. 2000 Jun;36(10):1248-57. Review.

PMID:
10882863
[PubMed - indexed for MEDLINE]
5.

Antiangiogenic strategies in neuroblastoma.

Ribatti D, Ponzoni M.

Cancer Treat Rev. 2005 Feb;31(1):27-34. Epub 2004 Nov 18. Review.

PMID:
15707702
[PubMed - indexed for MEDLINE]
6.

Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.

Wang JB, Wang MD, Li EX, Dong DF.

Peptides. 2012 Dec;38(2):457-62. doi: 10.1016/j.peptides.2012.09.007. Epub 2012 Sep 14. Review.

PMID:
22985857
[PubMed - indexed for MEDLINE]
7.

Anti-angiogenesis in neuroblastoma.

Ribatti D.

Crit Rev Oncol Hematol. 2013 Jun;86(3):212-21. doi: 10.1016/j.critrevonc.2012.11.004. Epub 2012 Dec 28. Review.

PMID:
23273512
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk